NEW YORK In an interview with the Wall Street Journal on Wednesday, Johnson & Johnson chairman and CEO William Weldon outlined a number of organizational changes taking place across the company in light of the recent spate of recalled products at McNeil Consumer Healthcare, a J&J company.
First, there is the creation of a corporate oversight group, headed by Ajit Shetty, who will be in charge of operations for the company’s pharmaceuticals, medical device and consumer segments. Shetty will report directly to Weldon.
